Literature DB >> 31584470

Third-Generation LVADs: Has Anything Changed?

Avi Levine1, Alan Gass.   

Abstract

The field of durable left ventricular assist devices has advanced dramatically since its introduction into the clinical realm. From the first-generation pulsatile HeartMate XVE device to the second-generation continuous axial flow HeartMate-2 to the current third-generation centrifugal flow devices, the left ventricular assist device has undergone significant evolution. This review describes the technology and its changes over the course of time, with a focus on the fundamental question: Has anything changed?

Mesh:

Year:  2019        PMID: 31584470     DOI: 10.1097/CRD.0000000000000268

Source DB:  PubMed          Journal:  Cardiol Rev        ISSN: 1061-5377            Impact factor:   2.644


  5 in total

Review 1.  Antithrombotic therapy for durable left ventricular assist devices - current strategies and future directions.

Authors:  Noah Weingarten; Cindy Song; Amit Iyengar; David Alan Herbst; Mark Helmers; Danika Meldrum; Sara Guevara-Plunkett; Jessica Dominic; Pavan Atluri
Journal:  Indian J Thorac Cardiovasc Surg       Date:  2022-09-21

2.  Sex-Based Heart Transplant Outcomes After Bridging With Centrifugal Left Ventricular Assist Devices.

Authors:  Lauren V Huckaby; Laura M Seese; Edgar Aranda-Michel; Michael A Mathier; Gavin Hickey; Mary E Keebler; Ibrahim Sultan; Thomas G Gleason; Arman Kilic
Journal:  Ann Thorac Surg       Date:  2020-05-04       Impact factor: 4.330

3.  A mortality risk score for heart transplants after contemporary ventricular assist device bridging.

Authors:  Lauren V Huckaby; Laura M Seese; Gavin Hickey; Ibrahim Sultan; Arman Kilic
Journal:  J Card Surg       Date:  2020-12-07       Impact factor: 1.778

Review 4.  Novel Targets for a Combination of Mechanical Unloading with Pharmacotherapy in Advanced Heart Failure.

Authors:  Agata Jedrzejewska; Alicja Braczko; Ada Kawecka; Marcin Hellmann; Piotr Siondalski; Ewa Slominska; Barbara Kutryb-Zajac; Magdi H Yacoub; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

5.  The role of renin-angiotensin system in patients with left ventricular assist devices.

Authors:  Alexandros Briasoulis; Ernesto Ruiz Duque; Dimitrios Mouselimis; Anastasios Tsarouchas; Constantinos Bakogiannis; Paulino Alvarez
Journal:  J Renin Angiotensin Aldosterone Syst       Date:  2020 Oct-Dec       Impact factor: 1.636

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.